Acura Pharmaceuticals, Inc. (ACUR)
|Net Income (ttm)||-1.21M|
|Trading Day||May 10|
|Day's Range||0.3610 - 0.4250|
|52-Week Range||0.1500 - 0.4500|
There are no news available yet.
Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. The company has six add... [Read more...]
Drug Manufacturers-Specialty & Generic
|Stock Exchange |
|Ticker Symbol |
In 2020, ACUR's revenue was $3.57 million, an increase of 34.36% compared to the previous year's $2.66 million. Losses were -$1.21 million, -67.99% less than in 2019.